Crystalvue Medical Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 209.66 million compared to TWD 180.09 million a year ago. Net income was TWD 35.74 million compared to TWD 17.06 million a year ago. Basic earnings per share from continuing operations was TWD 1.4286 compared to TWD 0.6762 a year ago. Diluted earnings per share from continuing operations was TWD 1.4095 compared to TWD 0.6762 a year ago. Basic earnings per share was TWD 1.4286 compared to TWD 0.6762 a year ago. Diluted earnings per share was TWD 1.4095 compared to TWD 0.6762 a year ago.
For the nine months, sales was TWD 563.81 million compared to TWD 528.33 million a year ago. Net income was TWD 84.41 million compared to TWD 53.68 million a year ago. Basic earnings per share from continuing operations was TWD 3.3714 compared to TWD 2.1429 a year ago. Diluted earnings per share from continuing operations was TWD 3.3238 compared to TWD 2.1238 a year ago. Basic earnings per share was TWD 3.3714 compared to TWD 2.1429 a year ago. Diluted earnings per share was TWD 3.3238 compared to TWD 2.1238 a year ago.